Alendronat Teva 70 mg tabletter, Placebo 8 mm with scoreline clinical trials

Markers of bonestatus in Diabetes Mellitus patients (type 1 and type 2) and the effect of antiresorptive treatment on glycemic markers

This study looks at how a common medicine for weak bones (osteoporosis) in people with diabetes might affect their blood sugar and bone health. Researchers want to see if this bone medicine changes blood sugar levels and markers related to bone strength in people with type 1 or type 2 diabetes.